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Abstract
Objective
To identify factors associated to poor glycemic control among diabetic patients seen at
primary health care centers.
Methods
A cross-sectional study was carried out in a sample of 372 diabetic patients attending
32 primary health care centers in southern Brazil. Data on three hierarchical levels of
health unit infrastructure, medical care and patient characteristics were collected.
Results
The frequency of poor glycemic control was 50.5%. Multivariate analysis (multilevel
method) showed that patients with body mass indexes below 27 kg/m2, patients on
oral hypoglycemic agents or insulin, and patients diagnosed as diabetic over five
years prior to the interview were more likely to present poor glycemic control when
compared to their counterparts.
Conclusions
Given the hierarchical data structuring, all associations found suggest that factors
associated to hyperglycemia are related to patient-level characteristics.
Resumo
Objetivo
Identificar fatores associados à falta de controle glicêmico em pacientes diabéticos
atendidos em centros de atenção primária à saúde.
Métodos
Estudo transversal em amostra de 372 pacientes diabéticos atendidos nos 32 centros
de atenção primária de uma cidade do sul do Brasil. Foram coletados dados ordenados
em três níveis hierárquicos: estrutura das unidades de saúde, características do
processo do cuidado médico e pacientes diabéticos.
Resultados
A freqüência de falta de controle glicêmico foi de 50,5%. A análise multivariada
(método multinível) mostrou que pacientes com Índice de Massa Corporal abaixo de
27 kg/m2, em tratamento medicamentoso e com mais de cinco anos de diagnóstico de
diabetes, tiveram maior probabilidade de apresentar hiperglicemia quando
comparados a seus pares.
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Conclusões
Considerando a estrutura hierárquica dos dados, todas as associações encontradas
sugerem que os fatores associados à hiperglicemia são relacionados a características
dos pacientes.
INTRODUCTION
The association between diabetes complications
and high glucose levels was postulated in the early
twentieth century. Only during the last three decades,
however, clinical research performed on diabetic pa-
tients directly associated hyperglycemia to the de-
velopment of complications.1 Adequate diabetes care,
which includes glycemic control and early screening
and treatment for end-organ damage, can prevent the
appearance of severe complications. The greatest chal-
lenge, however, resides in the fact that the treatment
of such a complex disease requires multiple proc-
esses and decisions which involve both healthcare
providers and patients. Despite the numerous techni-
cal advances observed in diabetes control and evalu-
ation, diabetes care remains, perhaps, the most com-
plex chronic disease to be managed at the primary
health care level.12
There is a lack of studies in the literature designed to
assess effectiveness of care of diabetic patients who
are cared by primary health care physicians. The pur-
pose of this study was to identify factors associated to
poor glycemic control among diabetic patients seen at
the primary health care network (PHCN).
METHODS
A cross-sectional study was conducted in the city of
Pelotas, southern Brazil, between May and December
1998. A city of 320,000 inhabitants, 30% of Pelotas’
population are regular users of the PHCN. Coverage of
this system reaches mainly individuals from poor so-
cial classes. The sample size was calculated to detect a
2 prevalence ratio, given a 20% prevalence of glycemic
control among unexposed individuals. This preva-
lence was identified by a cross-sectional study per-
formed in a primary health care facility.2 The exposure
used for calculating the sample size was compliance
with the recommended diet. In the aforementioned
study it was observed for one in four subjects. Assum-
ing 80% power and a 5% significance level, it resulted
in a sample of 232 diabetic patients. This was increased
by 15% for confounder control, and by 15% for possi-
ble losses and refusals, leading to a total sample of 372
subjects. During the study period, the PHCN in the
city’s urban area comprised 32 health centers. A trained
field worker visited every health center and examined
all claims that would be submitted for federal reim-
bursement searching for registries of diabetes diag-
noses. In two non-consecutive weeks every health
center was screened to identify at least 15 diabetic
patients, who attended a medical visit in the previous
seven days. At centers where the number of diabetic
patients identified were smaller than 15, the screening
was extended by a further 15 days, after which it was
interrupted at the number already found.
Each subject received a home visit during the week
following consultation. To be included in the study,
the patient was required to be aware of his/her dia-
betic condition, to live within the city’s urban area,
and not to be hospitalized at the time of the inter-
view. A pre-tested structured questionnaire was ap-
plied by trained interviewers in order to identify the
following characteristics: demographics (gender, race,
marital status, and age); socio-economic data (years
of schooling and income); disease history (time span
since diagnosis, family history, and hospitalization
during the preceding year); self-reported co-morbidi-
ties (heart or kidney disease, retinopathy, and sys-
temic arterial hypertension); self-reported compliance
with the treatment prescribed (diet, physical activity,
and medication), smoking history, and number of vis-
its in the preceding six months.
At the end of the interview patients were weighed
and their height was measured by study personnel
using a portable scale and anthropometer. The body
mass index (BMI) was calculated as weight (kg) di-
vided by height squared (m2). Blood pressure was
measured in seated position, once on each arm, and
measurements were corrected for arm perimeter,15 and
the average of both arms was registered. Aneroid
sphygmomanometers, calibrated monthly, were em-
ployed. Capillary glycemia was measured at house-
holds with a Glucotrend brand (Boehringer Mannheim).
The values set for determining poor glycemic con-
trol (dependent variable) were based upon levels de-
fined by the American Diabetes Association (ADA)1
and the Latin American Diabetes Association
(ALAD).* Results over 10 mmol/L (180 mg/dL) were
considered hyperglycemia.
*Guias ALAD 2000. [For diagnosis and management of type-2 diabetes mellitus with evidence-based medicine].  Available at http://www.alad.org/guiasalad.html [9 Ago 2004]
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Health center infrastructure and medical care were
also assessed and have been published previously.3
Briefly, information on medication and supplies avail-
ability (oral hypoglycemic agents, insulin, and blood
glucose strips); adoption of a specific diabetes man-
agement program; use of special registration forms for
diabetic patients; health center opening hours; ap-
pointment scheduling; and distribution of educational
material directed to self-care of diabetic patients, were
gathered by interviewing health facilities’ managers.
All medical doctors attending diabetic patients in every
health center were interviewed concerning their medi-
cal specialty, current number of jobs, duration of ten-
ure at the health center, and self-reported satisfaction
with care delivered. Based upon recommendations from
the American Diabetes Association,1 the quality of the
care provided was assessed by asking medical doctors
about physical examination and case management at
their first contact with patients already known to have
diabetes. Right answers should include, at least, meas-
ure of the patient’s weight, prescription of diet and
physical activity, and request of glycated hemoglobin
test. Also, medical records were analyzed for at least
one record of weight, blood pressure, and glycemia
during the preceding year.
To check reliability of the data collected, 10% of the
interviews with health center managers, physicians,
and patients, randomly selected, were repeated by the
fieldwork supervisor. The Kappa test results were al-
ways higher than 0.85. This study has been approved
by the Ethics Committee of the Faculdade de Medicina
da Universidade Federal de Pelotas and Secretaria
Municipal de Saúde. Data analyses were conducted
by logistic regression (multilevel method).10 A multi-
variate model, aiming at taking into account the inter-
dependence between patients attending the same PHC
center, was used. The highest hierarchical level was
the PHC center, the second level was the physicians,
and the third level was the patients. Analyses were car-
ried out according to a conceptual model for deter-
mining poor glycemic control.
Considering the differences in diabetic patient
enrollment time among the various health facilities, as
well as the possibility that patients seen at centers with
lower demand could hence be managed less efficiently
and, consequently, have worse disease control, data
were weighted according to the number of patients per
health center. After weighting, however, the propor-
tion of patients with poor glycemic control did not
change more than 1%, and thus this procedure was not
taken into account in subsequent analyses.
RESULTS
A total of 461 diabetic patients were identified. Of
these, 65 were excluded: three died before the inter-
view; five were hospitalized; 13 lived in other cities;
and 44 were not aware of having diabetes. Of 396
eligible patients, eight refused to be interviewed and
ten were not found at home after three visits on differ-
ent days and at different times, which resulted in 4.5%
loss. Of 378 diabetic patients interviewed, 372 were
included in the study – four were under 20 years old
while inclusion criteria were for adult patients1 and
two refused capillary blood sampling. The number of
patients screened per facility ranged from two to 23.
Table 1 describes the distribution of glycemic levels
in relation to fasting period. A 50.5% prevalence of
poor glycemic control was found. The minimal post-
prandial period before blood collection was 1.5 hour.
Most measurements (77%) were performed after peri-
ods of fasting ranging between two and eight hours.
The frequency of glycemic control increased linearly
with the duration of the fasting period (p=0.02).
The majority of the subjects presenting hyperglyc-
emia was over 50 years old, had a family income of
fewer than three minimum wages, and up to eight years
of schooling. About 15% of them had a history of at
least one hospitalization due to diabetes since treat-
ment was initiated in the health center at which they
were identified. Among subjects who were diagnosed
as having diabetes over five years prior to the inter-
view, hypertension was the most prevalent self-reported
co-morbidity. One third of the subjects presented nor-
mal blood pressure, and about 43.1% had BMI below
27 kg/m2. As to treatment regimen, 84% said to be
using an oral hypoglycemic agent. Of the 143 hyperg-
Table 1 - Distribution of glycemic levels according to time since last meal. Pelotas, Brazil, 1998.
Fasting time Glycemia
(hours) N ≤10 mmol/L >10 mmol/L* Mean ± standard deviation
N (%) N (%) (mmol/L)**
1:30 27 11 (40.7) 16 (59.3) 13.08±6.91
1:31-2:00 34 14 (41.2) 20 (58.8) 13.23±6.34
2:01-5:00 261 126 (48.3) 135 (51.7) 11.92±6.36
5:01-8:00 27 14 (51.9) 13 (48.1) 12.46±7.74
>8:00 23 19 (82.6) 4 (17.4) 8.23±4.15
Total 372 184 (49.5) 188 (50.5) 11.94±6.46
*Chi-square for trend, p=0.02
**ANOVA, p=0.04
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lycemic patients who reported having received dietary
advice, 49% said to have followed it in the last 15
days. The majority of patients (83%) had two or more
visits in the previous six months (Table 2).
Characteristics of facility infrastructure as well as
aspects of medical care of all patients included in the
study and those presenting hyperglycemia are de-
scribed in Table 3. Of all the patients seen at the health
centers, 10% followed some kind of diabetes care pro-
gram. Diabetic patients were assisted by 58 physi-
cians and 52% hyperglycemic patients were managed
by non-specialists, or by professionals specialized in
internal medicine or general practice. About 80% of
the patients were seen by physicians who worked at
the health centers for over one year. The majority was
seen by female physicians (65%), who had three or
more different jobs (63%), and who reported them-
selves as being satisfied with the available condi-
tions at the health facility for diabetic patient man-
agement. Table 3 shows that among patients using
oral hypoglycemic agents - OHA (n=246) or insulin
(n=40), 63.0% and 57.5% attended visits where those
medications were regularly available.
Of all subjects, 24 (6.5%) were seen by medical
doctors who reported that at their first contact with
an already known diabetic patient they would weigh
the patient, prescribe a diet and physical activity, and
request glycated hemoglobin for glycemic control
evaluation purposes (there were no restrictions for
this test in the PHCN). Considering 323 patients
whose records could be analyzed, for 166 (51%) of
them there was at least one record containing weight,
blood pressure, and glycemia levels.
Crude analysis showed that lower BMI, longer span
since diagnosis, insulin or oral hypoglycemic agent
treatment, and physician having many jobs were vari-
ables statistically associated to poor glycemic con-
trol. The multivariate analysis is described in Table 4.
Variables which remained associated to hyperglyc-
Table 2 - Distribution and frequency of glycemia according to demographic and socio-economic characteristics, self-
reported co-morbidities, disease history, and clinical management of patients.
Patient characteristics Total Glycemia >10 mmol/L
(N=372) (N=188)
Female 70.4 72.3
White skin color 75.8 76.1
Living with a partner 64.5 68.1
Age (years) 58.7±12.7 57.8±12.5
Age group (years)
≤50 25.3 28.2
51 to 60 29.3 28.7
61 to 70 27.2 26.6
≥71 18.2 16.5
Family monthly income (in minimum wages)
≤1 20.7 18.1
1.1-2.9 49.2 50.0
3.0-5.9 23.9 25.0
≥6 6.2 6.9
Schooling (years)
0 34.9 34.0
1-4 34.8 35.6
5-8 24.7 23.9
≥9 5.6 6.4
Diabetes for 5 years or longer 52.6 60.1
Diabetic family member 62.3 64.4
Hospitalization since started treatment at the primary health center 14.0 14.9
Self-reported co-morbidities*
Cardiovascular disease 37.5 35.4
Renal disease 15.8 11.5
Retinopathy 35.2 38.1
Arterial hypertension 67.3 67.3
Blood pressure ≤140x90** 37.8 34.4
BMI <27 kg/m2** 35.6 43.1
Current use of diabetes medication 75.5 84.0
Insulin 10.8 12.8
Oral hypoglycemic agent 66.5 73.3
Only diet*** 14.5 9.1
Complied with diet in the last 15 days 53.2 49.0
Physical exercise during last month 25.0 23.4
Current smoker 18.0 17.0
Medical visits in the last six months****
1 18.1 17.3
2 29.5 27.6
3 or more 52.4 55.1
Data: mean ± standard deviation or %
BMI: Body mass index
*Only subjects diagnosed as diabetic over 5 years prior to the interviews (N=196/113)
**N=370/186
***Only subjects who received dietary advice (N=282/183)
****N=366/185
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emia after controlling for family income, age, and
fasting time were BMI, use of pharmacological treat-
ment, and time span since diagnosis. Patients with
BMI below 27 kg/m2 had a 1.72 odds ratio (OR) (95%
CI 1.09-2.70) for poor glycemic control compared to
those with BMI equal or above 27 kg/m2. The odds
ratio for hyperglycemia in patients aware of their dis-
ease for over five years was about 70% higher than
that of diabetic patients with more recent diagnoses
(OR=1.69; 95% CI 1.09-2.63). Insulin or oral hy-
poglycemic agent use was also associated to poor
glycemic control (OR=2.56; 95% CI 1.49-4.34).
DISCUSSION
This study has simultaneously evaluated patient
demographic and socio-economic characteristics,
treatment regimens, health facility infrastructure data
and medical care delivered in a community-based
representative sample of primary care patients. Con-
sidering the reported 4% diabetes mellitus prevalence
among adults in urban Brazil14 and the 30%, Pelotas
PHCN utilization,6 the studied sample probably in-
cluded about 20% of all adult diabetic patients seen
by PHC physicians in the city.
The analysis performed through the multilevel
method is a positive aspect of this study. Contextual
or multilevel analysis challenge researchers to develop
conceptual models which are able to extend through
various levels and explain how group and subject-level
variables interact.7 When the units in each level share
a similar environment, or have similar characteristics,
such as patients seen by the same physician or physi-
Table 3 - Distribution and frequency of glycemia of patients according to service infrastructure and physician characteristics
of the primary health care system.
Characteristics Total Glycemia >10 mmo/L
(N=372) (N=188)
Service infrastructure
Diabetes patient care program 9.9 9.6
Working shifts per day
1 40.3 35.6
2 42.2 46.3
3 17.5 18.1
Educational material available 35.5 33.5
Scheduling of medical visits 48.7 50.0
Special records for diabetic patients 21.0 20.2
Capillary glycemia measuring bands available 16.1 15.4
OHA* available 63.0 63.5
Insulin** available 57.5 4.2
Physician characteristics***
Specialization in:
Internal medicine or general practice 43.1 44.8
Endocrinology 3.8 3.3
None or unrelated area 53.1 51.9
Female doctor 65.1 68.9
Current number of jobs
1-2 37.1 31.7
≥3 62.9 68.3
Duration of tenure at the health center (years)
<1 23.7 19.7
1-4 30.0 32.2
5-8 26.7 26.2
≥9 19.6 21.9
Data: mean ± standard deviation or %
*Only for oral Hypoglycemic Agent users (N=246/137)
**Only for insulin users (N=40/24)
***N=367/183
Table 4 - Crude and adjusted odds ratio (OR) for glycemia according to patient BMI, time span since diagnosis and use of
insulin or hypoglycemic agents.
Variable Crude OR p-value Adjusted OR* p-value
(95% CI) (95% CI)
BMI**<27 kg/m2 0.01 0.02
No 1.00 1.00
Yes 1.89 (1.20-2.86) 1.72 (1.09-2.70)
Time with diabetes 0.005 0.02
Less than 5 years 1.00 1.00
5 years or more 1.85 (1.22-2.78) 1.69 (1.09-2.63)
Use of insulin and/or OHA*** <0.001 <0.001
No 1.00 1.00
Yes 2.70 (1.59-4.35) 2.56 (1.49-4.34)
BMI: Body mass index
*Adjusted for family income, age and fasting time
**N=370
***OHA: Oral hypoglycemic agent
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cians of the same health facility, this assumed inde-
pendence is violated, and a correlation emerges among
the units of a same group.7,10 Such correlation can
render the use of traditional regression models infeasi-
ble for they are based upon the assumption that sub-
jects being studied are independent from one another
as well as from the outcome.
Apart from design constraints in terms of causality
determination, this study has other methodological
limitations that should be considered when interpret-
ing its findings. Other patient characteristics, as self-
care abilities and psychosocial adjustment for deal-
ing with the disease, for example, were not measured.
The main limitation, however, was how the assess-
ment of medical care was investigated. It was based
upon physicians self-reports, which could not always
be compared to visit records (13% of patient files
could not be located). In addition, the medical records
generally contained only very brief descriptions, if
any, being practically limited to the recording of blood
pressure and test results. Consultation observations
were not included in this study; these observations,
although likely to overestimate the performance of
certain procedures and managements, are indicated
when recording is poor.8
An interesting finding was that half of the patients
seen by internists or general practitioners had good
glycemic control, pointing out to the adequacy of
non-specialist medical doctors for managing diabetic
patients at the PHC level (Table 3).
The use of capillary glycemia is another limita-
tion of this study. Patient care should be evaluated
through diabetes control, and that this control
should be confirmed through glycated hemoglobin
measurement, preferably A
1c
 glycated hemoglobin
(HbA
1c
). In a local study,2 however, 30% of patients
did not show up for glycated hemoglobin measure-
ments, and a similar proportion would likewise be
expected in this study due to the similarities be-
tween the populations studied. Such high loss would
impair risk factor analysis.
Recent studies, however, have showed that post-
prandial hyperglycemia is an independent risk factor
for heart disease in type-2 diabetes patients. This sug-
gests that treatment efficacy evaluations cannot be
restricted to fasting plasma glucose and/or HbA
1c
evaluation,12,17,20 which would justify measurements
at other times of the day. Thus, the finding of 50%
hyperglycemic subjects in postprandial state or after
more hours of fasting a short time after consultation –
when all therapeutic recommendations should have
been reviewed and/or reinforced – is worrisome for it
indicates that these patients are likely to remain in
this state most of the time, which certainly has an
effect upon the evaluation of disease control and the
occurrence of complications.
In this study, no association (multilevel method)
was found between poor glycemic control and health
facility infrastructure or physician characteristics. It
showed to be associated, instead, to the patient char-
acteristics (time span since diagnosis, BMI and use
of pharmacological treatment).
Due to the high prevalence of the outcome studied,
however, risk estimates expressed as odds ratios were
surely overestimating the actual relative risk.18 The
crude odds ratios shown in Table 4, however, did not
change the direction of the effects seen in the preva-
lence ratios.
The observed association between hyperglycemia
and time span since diagnosis is consistent with the
literature5,9 suggesting that among diabetic patients
a decreased sensitivity to insulin or a progressive fail-
ure of pancreatic β-cells function develops over time.
Also in agreement with the literature is the observed
association between poor glycemic control and the
use of oral hypoglycemic agents,5,9 which remained
significant even after controlling for time span since
diagnosis. Corroborating to it is the fact that, in the
studied sample, 41% of the patients in use of an oral
hypoglycemic agent were taking dosages below or
above those considered clinically effective.4 A sub-
analysis of the patients receiving adequate dose, as an
independent variable, however, showed no significant
association with the glycemic control. Another aspect
to be considered is that drug prescription for type-2
diabetic patients is recommended only when dietary
and lifestyle changes fail to control the disease.19 Thus,
drug prescription is compatible with manifestations of
more severe forms of the disease, which go together
with a greater occurrence of poor glycemic control.
In the studied sample, BMIs below 27 kg/m2 were
associated to a greater likelihood of hyperglycemia.
This finding is consistent with the fact that in the non-
obese diabetic, mild to severe hyperglycemia is usu-
ally due to refractoriness of β-cells to glucose stimula-
tion. The resulting insulinopenia leads to weight loss,
a clinical manifestation of uncontrolled diabetes. Also,
since this study did not collect data on reasons for
consultation, the effect of infectious diseases over the
higher prevalence of hyperglycemia observed among
patients with BMI below 27 kg/m2 could not be ruled
out. In addition, it is an international consensus that
roughly 25% of type-2 diabetic patients are expected
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to require the use of insulin for glycemic control,16 and
that this type of treatment is more likely to be used by
slimmer patients.19 In Brazil this proportion is about
8%, possibly indicating a lack of training among medi-
cal doctors on insulin prescription to type-2 diabetic
patients.16 Reluctance of the latter’s in using this kind
of medication can not also be ruled out. The high preva-
lence of diabetes-related co-morbidities reported by
subjects diagnosed as diabetic over five years prior to
the interview is equally important. Even considering
that the study design does not allow analyses of tem-
porality, this finding suggests that these co-morbidities
can be due to poorly-controlled diabetes. The fre-
quency of these conditions, however, was obtained
through self-reporting, which is a limitation in this
study. For this reason, such characteristics were taken
into consideration for descriptive purposes only, not
being employed in the multivariate analysis.
In conclusion, inferences about the adequacy of
the impact of diabetic patients care at PHCN in Pelotas
can be properly drawn from this study.10 The results
showed that only half of the patients met the set crite-
ria for adequate glycemic control. Only variables at
the patient level showed to be statistically associated
with the outcome. Among those, the use of drug
therapy for diabetes management was most strongly
associated with poor glycemic control. Drug prescrip-
tion, however, is a medical action and part of the dis-
ease control depends upon its appropriateness. As is
the case in many PHC settings in developing coun-
tries, at the time of this study there was no diabetic
patient care program running at local level. From the
study results it seems that such a program is needed.
The totality of the health facilities should be appro-
priately equipped for diabetes care and protocols for
case management should be instituted as a mean of
care process orientation. Meanwhile, in the short term,
special attention must be given to patients diagnosed
as diabetic a long while ago, as well as to the ad-
equacy of drug prescription and to weight monitor-
ing of diabetic patients.
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